Ventilation following established ARDS: a preclinical model framework to improve predictive power.
Charlotte OakleyMarissa KohRhianna BaldiSanooj SoniKieran O'DeaMasao TakataMichael R WilsonPublished in: Thorax (2019)
We propose adoption of a practical framework like that described here to reduce the number of ultimately ineffective drugs reaching clinical trials. Novel targets should be evaluated alongside interventions which have been previously tested clinically, using models that recapitulate the (lack of) clinical efficacy. Within such a framework, outperforming a failed pharmacologic should be a prerequisite for drugs entering trials.